Government ContextGovernment Context
TopicsAgenciesDocumentsPricingLog inCreate account
Nonrulemaking

Request that the FDA determine and declare that Metformin Tablets 375 mg and 425 mg are suitable for submission in an Abbreviated New Drug Application (ANDA)

🏛 Food and Drug Administration (FDA)FDA-2026-P-7602
Documents
6
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 6Supporting & Related Material 4Other 2
📄 Primary document
OtherJul 8, 2026
Suitability Petition from Senores Pharmaceuticals, Inc
No comment period
Open →